Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Over Cancer”

491 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 491 results

Testing effectiveness (Phase 2)Looking for participantsNCT07192614
What this trial is testing

Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 52
Testing effectiveness (Phase 2)Study completedNCT03477175
What this trial is testing

Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials

Who this might be right for
Solid Tumors
Eisai Inc. 40
Testing effectiveness (Phase 2)Study completedNCT02159365
What this trial is testing

Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 84
Post-approval studies (Phase 4)Study completedNCT00478504
What this trial is testing

Letrozole Versus Clomifene Citrate for Ovulation Induction

Who this might be right for
InfertilityPolycystic Ovarian Syndrome
University of Nottingham 159
Testing effectiveness (Phase 2)Active Not RecruitingNCT01985087
What this trial is testing

A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70

Who this might be right for
Glioblastoma
University of Louisville 18
Not applicableStudy completedNCT02607293
What this trial is testing

Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation

Who this might be right for
Polycystic Ovary Syndrome
Merck KGaA, Darmstadt, Germany 1,064
Large-scale testing (Phase 3)Ended earlyNCT00272987
What this trial is testing

ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 63
Testing effectiveness (Phase 2)UnknownNCT05164393
What this trial is testing

Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK

Who this might be right for
Actinic Keratoses
Coegin Pharma AB 60
Not applicableStudy completedNCT02270021
What this trial is testing

Decreasing Over Screening and Treatment of Cervical Precancers in Young Women

Who this might be right for
Cervical Cancer
University of California, San Francisco 42
Not applicableStudy completedNCT05716958
What this trial is testing

Multi-Reader, Multi-Case, Cross-Over, Retrospective Study to Evaluate Effectiveness of Lunit INSIGHT DBT

Who this might be right for
Breast Cancer
Lunit Inc. 262
Early research (Phase 1)Study completedNCT06892756
What this trial is testing

Effect of Cyclosporine Drug Interaction on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers. Drug-Drug Interaction 2 (DDI2) Study

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Chiesi Farmaceutici S.p.A. 30
Not applicableLooking for participantsNCT07187219
What this trial is testing

Efficacy of Repetitive Transcranial Magnetic Stimulation Over the Primary Cortex in Patients With Neuropathic Pain and Cancer

Who this might be right for
CancerChronic Neuropathic Pain
Centre Hospitalier Universitaire de Saint Etienne 60
Post-approval studies (Phase 4)Looking for participantsNCT04877522
What this trial is testing

Asciminib Roll-over Study

Who this might be right for
Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Novartis Pharmaceuticals 347
Early research (Phase 1)Study completedNCT05567601
What this trial is testing

Doxil/Caelyx BE Study

Who this might be right for
Ovarian CancerAIDS-related Kaposi SarcomaMultiple Myeloma+1 more
Baxter Healthcare Corporation 36
Post-approval studies (Phase 4)Study completedNCT02049112
What this trial is testing

A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study

Who this might be right for
XerostomiaHyposalivationHead and Neck Cancer+1 more
Unither Pharmaceuticals, France 210
Not applicableStudy completedNCT01273597
What this trial is testing

Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands

Who this might be right for
Kidney Failure, Chronic
AbbVie (prior sponsor, Abbott) 60
Testing effectiveness (Phase 2)Study completedNCT02974868
What this trial is testing

Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 142
Testing effectiveness (Phase 2)Study completedNCT02383498
What this trial is testing

QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma

Who this might be right for
Chordoma
NantCell, Inc. 24
Early research (Phase 1)Study completedNCT02073916
What this trial is testing

T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Jenny C. Chang, MD 24
Not applicableStudy completedNCT04284540
What this trial is testing

Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Icahn School of Medicine at Mount Sinai 37
Load More Results